|
⚲
|
| Keyboard |
| Greco Theresa
✚
|
|
|---|---|
| CIK # | 0001998771 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001998771] | |
| 4 | [0001998771] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| OptimizeRx Corp | |
| Greco Theresa |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
OptimizeRx Corp OPRX
Common Stock
|
2025-12-23 | Tax withheld | 1,420 | $12.74 | 18,091 |
|
OptimizeRx Corp OPRX
Common Stock
|
2025-11-01 | Tax withheld | 1,693 | $20.49 | 34,690 |
|
OptimizeRx Corp OPRX
Common Stock
|
2025-05-15 | Grant | 2,441 | $0.00 | |
|
OptimizeRx Corp OPRX
Common Stock
|
2025-05-15 | Grant | 7,042 | $0.00 | |
|
OptimizeRx Corp OPRX
Stock Option · derivative
|
2025-05-15 | Grant | 12,133 | $0.00 | |
|
OptimizeRx Corp OPRX
Common Stock
|
2024-12-23 | Grant | 15,528 | $0.00 | |
|
OptimizeRx Corp OPRX
Stock Option · derivative
|
2024-12-23 | Grant | 29,153 | $0.00 | |
|
OptimizeRx Corp OPRX
Common Stock
|
2024-11-01 | Tax withheld | 1,693 | $5.15 | 8,719 |
|
OptimizeRx Corp OPRX
Common Stock
|
2023-11-01 | Grant | 18,519 | $0.00 | |
|
OptimizeRx Corp OPRX
Stock Option · derivative
|
2023-11-01 | Grant | 35,758 | $0.00 |